Kumar Anand, Schupp Elizabeth, Bunnell Eugene, Ali Amjad, Milcarek Barry, Parrillo Joseph E
Section of Critical Care Medicine, Health Sciences Centre/St, Boniface Hospital, University of Manitoba, Winnipeg, Manitoba, Canada.
Crit Care. 2008;12(2):R35. doi: 10.1186/cc6814. Epub 2008 Mar 4.
During septic shock, resistance to the haemodynamic effects of catecholamine vasopressors and inotropes is a well-recognised marker of mortality risk. However, the specific cardiovascular or metabolic response elements that are most closely associated with outcome have not been well defined. The objective of this study was to assess cardiovascular and metabolic responses to dobutamine as correlates of outcome in patients with severe sepsis or septic shock.
A prospective, non-randomised, non-blinded interventional study of graded dobutamine challenge (0, 5, 10, and 15 mug/kg/min) in adult patients who had undergone pulmonary artery catheterisation within 48 hours of onset of severe sepsis or septic shock (8 survivors/15 non-survivors) was performed. Radionuclide cineangiography during graded infusion was used to determine biventricular ejection fractions at each increment of dobutamine.
In univariate analysis, a variety of cardiovascular or haemodynamic and oxygen transport or metabolic variables (at the point of maximum cardiac index response for a given subject) were associated with survival including: increased stroke volume index (p = 0.0003); right ventricular end-diastolic volume index (p = 0.0047); left ventricular stroke work index (p = 0.0054); oxygen delivery index (p = 0.0084); cardiac index (p = 0.0093); systolic blood pressure/left ventricular end-systolic volume index ratio (p = 0.0188); left ventricular ejection fraction (p = 0.0160); venous oxygen content (p = 0.0208); mixed venous oxygen saturation (p = 0.0234); pulse pressure (p = 0.0403); decreased pulmonary artery diastolic pressure (p = 0.0133); systemic vascular resistance index (p = 0.0154); extraction ratio (p = 0.0160); and pulmonary vascular resistance index (p = 0.0390). Increases of stroke volume index of greater than or less than 8.5 mL/m2 were concordant with survival or death in 21 of 23 cases. Multivariate profile construction showed stroke volume index as the dominant discriminating variable for survival with the systolic blood pressure/left ventricular end-systolic volume index ratio alone among all other variables significantly improving the model.
Survivors maintain cardiac responsiveness to catecholamine stimulation during septic shock. Survival from severe sepsis or septic shock is associated with increased cardiac performance and contractility indices during dobutamine infusion. Further studies are required to determine whether these parameters are predictive of outcome in a larger severe sepsis/septic shock population.
在感染性休克期间,对儿茶酚胺类血管加压药和正性肌力药的血流动力学效应产生抵抗是公认的死亡风险标志物。然而,与预后最密切相关的特定心血管或代谢反应因素尚未明确界定。本研究的目的是评估多巴酚丁胺对严重脓毒症或感染性休克患者的心血管和代谢反应,并将其作为预后的相关因素。
对在严重脓毒症或感染性休克发作48小时内接受肺动脉导管插入术的成年患者(8名幸存者/15名非幸存者)进行了一项前瞻性、非随机、非盲法的多巴酚丁胺分级挑战(0、5、10和15微克/千克/分钟)干预研究。在分级输注过程中,采用放射性核素心血管造影术测定多巴酚丁胺每次增量时的双心室射血分数。
在单变量分析中,多种心血管或血流动力学以及氧输送或代谢变量(在给定受试者的最大心脏指数反应点)与生存相关,包括:每搏量指数增加(p = 0.0003);右心室舒张末期容积指数(p = 0.0047);左心室每搏功指数(p = 0.0054);氧输送指数(p = 0.0084);心脏指数(p = 0.0093);收缩压/左心室收缩末期容积指数比值(p = 0.0188);左心室射血分数(p = 0.0160);静脉血氧含量(p = 0.0208);混合静脉血氧饱和度(p = 0.0234);脉压(p = 0.0403);肺动脉舒张压降低(p = 0.0133);全身血管阻力指数(p = 0.0154);提取率(p = 0.0160);以及肺血管阻力指数(p = 0.0390)。每搏量指数增加大于或小于8.5 mL/m²与23例中的21例生存或死亡一致。多变量特征构建显示,每搏量指数是生存的主要判别变量,在所有其他变量中,仅收缩压/左心室收缩末期容积指数比值显著改善了模型。
感染性休克期间,幸存者对儿茶酚胺刺激保持心脏反应性。严重脓毒症或感染性休克的存活与多巴酚丁胺输注期间心脏功能和收缩性指标的增加有关。需要进一步研究以确定这些参数是否能预测更大规模严重脓毒症/感染性休克人群的预后。